Physician profile
Michael C Solomon
NPI 1023070539
$11,809.64
in general payments reported to CMS, 2019-2025
36 companies · $1,023 in 2025
The $1,023 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $1,420 · 2021: $1,555 · 2022: $4,543 · 2023: $1,152 · 2024: $912 · 2025: $1,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,745 · Education: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,744.86 |
| Education | $341.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $5,154.04 | 2019-2025 | Xtandi, Padcev, Myrbetriq |
| Myriad Genetic Laboratories, INC. | $1,607.27 | 2021-2025 | Prolaris, Myrisk |
| Neotract INC. | $753.25 | 2020 | |
| Pfizer INC. | $721.02 | 2019-2025 | |
| Janssen Biotech, INC. | $539.78 | 2019-2022 | |
| Urogen Pharma, INC. | $297.49 | 2021-2023 | Jelmyto |
| Teleflex LLC | $289.60 | 2020-2021 | |
| United Medical Systems (De), INC. | $230.34 | 2021 | |
| Coloplast Corp | $212.92 | 2019-2024 | |
| Abbvie INC. | $211.82 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $189.95 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Esense 7fr Abdominal Catheter |
| Calyxo, INC. | $184.81 | 2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $144.13 | 2019-2022 | |
| Tolmar, INC. | $135.09 | 2023-2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $126.17 | 2023-2025 | Gemtesa, Orgovyx |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $118.14 | 2024-2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $106.73 | 2021-2022 | |
| Boston Scientific Corporation | $99.98 | 2019-2022 | |
| Convatec INC. | $82.45 | 2020-2023 | |
| Ferring Pharmaceuticals INC. | $65.73 | 2019-2020 | |
| Karl Storz Endoscopy-America | $62.53 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $59.30 | 2019-2022 | |
| Healthtronics Stone Solutions, LLC | $59.18 | 2021 | |
| Myovant Sciences INC. | $53.18 | 2021-2022 | |
| Allergan, INC. | $43.62 | 2019-2022 | |
| Clarus Therapeutics INC. | $43.11 | 2021 | |
| Urovant Sciences INC | $39.07 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Kowa Pharmaceuticals America, INC. | $26.76 | 2023 | Seglentis |
| Dentsply Ih INC. | $25.12 | 2021 | |
| Merck Sharp & Dohme LLC | $22.17 | 2021 | |
| Endo Pharmaceuticals INC. | $21.49 | 2022 | |
| Axonics, INC. | $14.26 | 2022 | |
| Alnylam Pharmaceuticals INC. | $13.13 | 2021 | |
| Accord Healthcare, INC. | $12.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.